A: BPC-157 has an excellent safety record
Clinical trials targeting E/I balance, transcriptional and epigenetic regulation, immune regulation, biological peptides and intestinal flora are advancing in an orderly manner (Table 3)
Originally studied for its effects on gastric ulcers and intestinal health, BPC-157 has since demonstrated benefits in healing tendons, ligaments, muscles, nerves, and even the brain
Retatrutide's triple-agonist mechanism (GLP-1 + GIP + glucagon) produces diarrhea in approximately 34% of users at 12 mg, compared to roughly 30% for semaglutide at 2.4 mg
These injections often contain vitamin B12, which is considered safe in large quantities
Recovery peptides like BPC-157 and TB-500 target tissue repair